The company will receive an upfront payment of Euro 100 million (Rs. 880 crores) for product development and site approval from European authorities
Divestment is part of BASF’s strategic portfolio optimization
Exploring new opportunities within the fast-growing market of microfluidics
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
This product is categorized as antacids, antiflatulents and anti-Ulcerants
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
The publication serves as a foundational tool for identifying gaps and addressing needs in various areas, including rural, urban, and tribal regions
ForDoz Pharma Corporation, USA (ForDoz) received an approval for its ANDA from the USFDA
Subscribe To Our Newsletter & Stay Updated
